Figure 3.
Meta-analysis estimates of virologic failure (VF) incidence after switch to dolutegravir plus lamivudine in people with human immunodeficiency virus type 1 with historical M184V/I from targeted literature review–identified interventional studies, inclusive of all VF definitions. Abbreviations: CI, confidence interval; PWH, people with human immunodeficiency virus type 1; VF, virologic failure; Wt, weight.